Bio-Rad Laboratories, Inc.
Hercules, CA
- UEI
- YSLYWJ39JM33
- CAGE
- 1M2Q8
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
-
- 325414 Biological Product (except Diagnostic) Manufacturing
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- 334516 Analytical Laboratory Instrument Manufacturing
- 334519 Other Measuring and Controlling Device Manufacturing
- 339112 Surgical and Medical Instrument Manufacturing
- 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
- 532490 Other Commercial and Industrial Machinery and Equipment Rental and Leasing
- 541519 Other Computer Related Services
- Corporate family
-
-
- Feldkirchen, BY WRZLAH8SEPG3
- Hercules, CA KBN4ZDJ47ZB9
- MWPKHDKYNKM3
- GBL8EGPR37N5
- Krung Thep Maha Nakhon GF32DGK32UK8
- Segrate, Lombardia QNR9KXU1K1J5
- FBHGB46JPJU1
- Bio Rad Laboratories SA XK1DV7BNFDT6
- D1PMPE28XXA1
- Bio-Rad Laboratories, Inc. · Hercules, CA SSHPDYFGN7J9
- Bio-Rad Laboratories, Inc. NU6KQEPZHYG8
-
- SAM.gov registration date
- Physical address
- 1000 Alfred Nobel Dr, Hercules, CA 94547, USA
- Website
- bio-rad.com
- Founded
- 1952
- Employees
- 5K-10K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $846,997 |
| FY2025 | $757,625 |
| FY2024 | $209,103 |
| FY2023 | $375,909 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $394,740 | |
| 2 | Department of Health and Human Services | $269,662 | |
| 3 | Department of the Navy | $98,325 | |
| 4 | Department of Agriculture | $59,275 | |
| 5 | Department of the Interior | $24,995 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Canon U.s.a., Inc. | 75N91025F00012 | $53,377 | |
| Government Scientific Source Inc. | 75N91025F00016 | $98,597 | |
| Weems Design Studio, Inc. | 75N91024F00011 | $110,908 | |
| New TECH Solutions, Inc. | 75N91023F00019 | $32,000 | |
| University Of California, San Diego | HDTRA121C0019 | $51,160 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Takara Bio Usa, Inc. | San Jose, CA | 325414 Biological Product (except Diagnostic) Manufacturing |
| US Customer Operations | Brea, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Ted Pella, Inc. | Redding, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Fisher Healthcare | Pittsburgh, PA | 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers |
| Fluidigm | South San Francisco, CA | 334516 Analytical Laboratory Instrument Manufacturing |
About the company
Bio-Rad Laboratories, Inc., a for-profit manufacturer of life science research and clinical diagnostic instruments headquartered in Hercules, California, supplies laboratory equipment, reagents, consumables, and maintenance services to federal agencies as a prime contractor on full-and-open purchase orders and blanket purchase agreements. Bio-Rad competes without set-aside designations across its federal footprint and holds no exclusive seats on government-wide IDIQs or GWACs; the vendor operates as a pure commercial supplier, leveraging proprietary equipment platforms (ChemiDoc imaging systems, QX200/QX600 droplet digital PCR systems, CFX real-time PCR instruments, BioRad BioPlex multiplex analyzers, Bio-Rad chromatography systems) that drive sole-source justifications under FAR 12.603 streamlined procedures.
Bio-Rad's federal customer base spans 49 distinct agencies with shallow concentration at the award-count level — the Department of Veterans Affairs, Department of the Army, and Department of the Navy together account for 31% of recent awards (93 total) — but significant dollar concentration among specialty users. By combined potential value, the top tier sits with the Department of Agriculture Animal and Plant Health Inspection Service Wildlife Services (5 awards, $3.1 million, primarily for Reliance One-Step Multiplex Supermix PCR reagents under a $1.5 million BPA established in 2022), Veterans Integrated Service Network 12 at the Department of Veterans Affairs (4 awards, $715 thousand for BioPlex maintenance), and the Indian Health Service (6 awards, $296 thousand for quality control and chemistry supplies). Recent named prime work includes a $450 thousand purchase order from Veterans Integrated Service Network 12 for BioPlex reagents and supplies (September 2026), a $396.9 thousand firm fixed-price order from Veterans Integrated Service Network 22 for immunology testing supplies including ANA testing reagents (February 2025), a $196.4 thousand maintenance contract from the Department of Agriculture for four Bio-Plex 100/200 systems running through June 2030 (July 2025), and an $81.6 thousand equipment purchase from the Bureau of Medicine and Surgery for two CFX Opus 96 DX instruments (May 2026). Equipment orders dominate the portfolio — ChemiDoc blot imaging systems, QX600 digital PCR systems, and CFX Opus 96 real-time PCR platforms recur across the National Cancer Institute, National Human Genome Research Institute, National Institute of Neurological Disorders and Stroke, and USGS.
Bio-Rad's position on federal supply schedules anchors the largest vehicle footprint. The Federal Supply Schedule V797P5293N carries 85 task orders (combined potential value $312 thousand), followed by GS24F1238C with 33 task orders ($45 thousand), GS24F2036D with 14 task orders, and V797P5903J with 6 task orders ($20 thousand). These schedules facilitate recurring direct purchases and small call orders from civilian research and healthcare facilities. The vendor also holds single-award blanket purchase agreements with the Department of Agriculture Wildlife Services (BPA 12639523A0012, $1.5 million ceiling through September 2027 for PCR reagents), the Department of the Interior USGS (IDC ceiling $149.1 thousand through September 2028 for QX200/AutoDG supplies), and the Indian Health Service (BPA ceiling $150 thousand, expired August 2023), enabling pre-negotiated pricing for routine consumable restocking. No multi-award GWACs or agency-wide IDIQs appear in the source.
Activity has grown modestly — 10 awards in 2022 to 15 in 2026 year to date — with fourteen awards (combined potential value $882 thousand) completing within the next twenty-four months, presenting recompete opportunities primarily among maintenance and consumables renewals. In its minimal subcontractor role, Bio-Rad supplies specialized equipment and services to Canon USA, Government Scientific Source Inc., New TECH Solutions, Inc., and Weems Design Studio, Inc. on NCI operational task orders and NIAID research contracts, with the University of California San Diego receiving Bio-Rad equipment for a cellular nanosponges medical countermeasure research sub-award.
The vendor's capability portfolio centers on proprietary or sole-source platforms: droplet digital PCR systems (QX200, QX600 series), real-time PCR instruments (CFX Opus, CFX96), multiplexing analyzers (BioPlex 2200, BioRad Evolis), chromatography systems, and associated reagents, consumables, and maintenance support. Awards are almost exclusively product sales and maintenance renewals under commercial item procedures (FAR Part 13 and 12.603). The federal footprint remains heavily concentrated in NAICS 334517 (Analytical Laboratory Instrument Manufacturing, 40 awards) and 334516 (In-Vitro Diagnostic Substance Manufacturing, 19 awards), with PSC codes Laboratory Equipment And Supplies (149 awards), Medical And Surgical Instruments (43 awards), and In Vitro Diagnostic Substances (43 awards) dominating the spend.
Bio-Rad's corporate structure includes eleven named subsidiaries, most located internationally (Bio-Rad ABD Serotec GMBH, Bio-Rad Laboratories S.R.L., Bio-Rad Laboratories LIMITED, subsidiaries in Singapore and France), with Gnubio Inc. listed as a for-profit subsidiary with grant-awarding capability, suggesting potential research revenue diversification outside the core equipment and reagent business. The parent entity operates as a large, non-small-business manufacturer without minority, veteran, women-owned, or other set-aside certifications, competing strictly on technical capability and established sole-source relationships anchored to proprietary equipment ecosystems.
Quick answers
Is Bio-Rad Laboratories, Inc. registered in SAM.gov?
Yes. Bio-Rad Laboratories, Inc.'s SAM.gov registration is active through October 5, 2027.
How much has Bio-Rad Laboratories, Inc. received in federal contracts?
Federal contracts obligated $757,625 to Bio-Rad Laboratories, Inc. in fiscal year 2025 and $2,189,633 in fiscal years 2023 through 2027.
How does Bio-Rad Laboratories, Inc. rank among federal contractors?
Bio-Rad Laboratories, Inc. ranked #23 in NAICS 325413, #25 in PSC N066 and #26 in PSC W066 in FY2025.
What is Bio-Rad Laboratories, Inc.'s most recent federal award?
Bio-Rad Laboratories, Inc.'s most recent federal contract award is Blots and gels imaging system with accompanying supplies (1232SA26P0632), from Central Program Planning Coordination and Support (ARS), on September 30, 2026.
On GovTribe
See Bio-Rad Laboratories, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors